Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.700 | None | 0.961 | 8 | 8 | 2002 | 2020 | ||||||||
|
BLK proto-oncogene, Src family tyrosine kinase | 0.585 | 0.769 | 8.3E-14 |
|
disease | 0.700 | None | 0.976 | 6 | 3 | 2008 | 2020 | ||||||||
|
complement C3 | 0.445 | 0.885 | 0.90 |
|
disease | 0.700 | limited | 1.000 | 6 | 1 | 2007 | 2020 | ||||||||
|
ankyrin 3 | 0.578 | 0.654 | 1.00 |
|
disease | 0.700 | None | 1.000 | 5 | 31 | 2008 | 2020 | ||||||||
|
complement factor B | 0.532 | 0.769 | 4.7E-16 |
|
disease | 0.700 | limited | 0.966 | 5 | 3 | 2006 | 2019 | ||||||||
|
transcription factor 4 | 0.464 | 0.846 | 1.00 |
|
disease | 0.700 | None | 1.000 | 5 | 4 | 1999 | 2019 | ||||||||
|
wolframin ER transmembrane glycoprotein | 0.528 | 0.846 | 1.6E-38 |
|
disease | 0.700 | strong | 0.974 | 5 | 5 | 2002 | 2020 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.800 | 5 | 4 | 2008 | 2020 | ||||||||
|
interleukin 23 receptor | 0.466 | 0.769 | 5.6E-04 |
|
disease | 0.700 | None | 0.982 | 4 | 3 | 2006 | 2020 | ||||||||
|
unc-13 homolog A | 0.705 | 0.423 | 1.00 |
|
disease | 0.700 | None | 1.000 | 4 | 1 | 2009 | 2019 | ||||||||
|
integrin subunit alpha M | 0.443 | 0.808 | 3.3E-11 |
|
disease | 0.700 | None | 1.000 | 4 | 6 | 2008 | 2019 | ||||||||
|
microseminoprotein beta | 0.498 | 0.846 | 1.6E-02 |
|
disease | 0.700 | None | 0.984 | 4 | 1 | 1993 | 2020 | ||||||||
|
IKAROS family zinc finger 1 | 0.533 | 0.769 | 1.00 |
|
disease | 0.700 | None | 1.000 | 3 | 6 | 2002 | 2019 | ||||||||
|
adenylate cyclase 5 | 0.617 | 0.577 | 1.00 |
|
disease | 0.700 | None | 0.947 | 3 | 2 | 2002 | 2019 | ||||||||
|
BTB domain containing 9 | 0.691 | 0.423 | 7.1E-09 |
|
disease | 0.700 | None | 0.967 | 3 | 7 | 2007 | 2020 | ||||||||
|
immunity related GTPase M | 0.617 | 0.538 |
|
disease | 0.700 | None | 0.939 | 3 | 3 | 2007 | 2020 | |||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.700 | None | 0.857 | 3 | 3 | 2007 | 2019 | ||||||||
|
interleukin 13 | 0.386 | 0.846 | 1.4E-02 |
|
disease | 0.700 | None | 0.982 | 3 | 1 | 1995 | 2020 | ||||||||
|
TNF alpha induced protein 3 | 0.481 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.929 | 3 | 3 | 2008 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
disease | 0.700 | None | 0.882 | 2 | 2 | 1995 | 2019 | ||||||||
|
alcohol dehydrogenase 1B (class I), beta polypeptide | 0.502 | 0.846 | 9.9E-07 |
|
disease | 0.700 | None | 1.000 | 2 | 2 | 1994 | 2019 | ||||||||
|
endothelial PAS domain protein 1 | 0.454 | 0.731 | 0.60 |
|
disease | 0.700 | None | 0.974 | 2 | 17 | 2001 | 2019 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.700 | None | 0.939 | 2 | 2 | 1980 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.700 | None | 0.882 | 2 | 4 | 1990 | 2019 | ||||||||
|
interferon regulatory factor 5 | 0.489 | 0.731 | 9.0E-03 |
|
disease | 0.700 | None | 0.949 | 2 | 1 | 2005 | 2020 |